FDA approves once-a-day pill for common skin cancer
Friday, July 24, 2015 - 13:50
in Health & Medicine
Stephen FellerSILVER SPRING, Md., July 24 (UPI) -- The FDA announced that it approved the once-a-day pill Odomzo for patients with recurrent basal cell carcinoma or who can't have surgery or radiation therapy.